Mini Review Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/AIDS.1.001
CCR5 Inhibitors and HIV-1 Infection
Olga S. Latinovic1,2,*, Marvin Reitz1, Alonso Heredia1,3
- 1Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA
- 2Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA
- 3School of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
Corresponding Author
Olga S. Latinovic, olatinovic@ihv.umaryland.edu
Received Date: December 10, 2018
Accepted Date: December 12, 2018
Citation:
Latinovic OS, Reitz M, Heredia A. CCR5 Inhibitors and HIV-1 Infection. Journal of AIDS and HIV Treatment. 2018; 1(1):1-5.
Copyright: © 2018 Latinovic OS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Plant-Based Vaccines Against Infectious Human Viral Diseases: Spotlight on HIV Vaccines
Production of high value recombinant pharmaceuticals using plant-based systems, otherwise called molecular pharming has greatly advanced over the past few years.